Corrigendum: Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries

Affiliations

• ¹ Department of Medical Sciences, Surgery and Neurosciences, Research Center of Systemic Autoinflammatory Diseases and Behçet's Disease Clinic, University of Siena, Siena, Italy.
• ² Azienda Ospedaliero-Universitaria Senese [European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center], Siena, Italy.
• ³ Rheumatology Department, Hospital de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
• ⁴ Rheumatology and Clinical Immunology Unit, Internal Medicine Department, Faculty of Medicine, Cairo University, Giza, Egypt.
• ⁵ Faculty of Medicine, Newgiza University, 6th of October City, Egypt.
• ⁶ Department of Autoimmune Diseases, Institut d'Investigacions Biomèdiques August Pi I Sunyer, Hospital Clínic of Barcelona [European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA) Center], University of Barcelona, Barcelona, Spain.
• ⁷ Neuroscience Research Group (NEUROS), NeuroVitae Center, Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia.
• ⁸ Department of Ophthalmology, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain.
• ⁹ Department of Ophthalmology, Hospital Universitario Rey Juan Carlos, Madrid, Spain.
• ¹⁰ Department of Ophthalmology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
• ¹¹ Department of Ophthalmology, Cairo University, Giza, Egypt.
• ¹² Bioengineering and Biomedical Data Science Lab, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
• ¹³ Ophthalmology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.